• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    1/2/24 1:35:24 PM ET
    $ADTX
    $AHG
    $ALLO
    $AMPX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate
    Real Estate
    Get the next $ADTX alert in real time by email

    Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) rose sharply during Tuesday’s session after the company released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs).

    Longboard Pharmaceuticals shares jumped 199.7% to $18.07 on Tuesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Akso Health Group (NASDAQ:AHG) surged 85% to $1.2946.
    • Polished.com Inc. (NYSE:POL) gained 45% to $8.77.
    • Dogness (International) Corporation (NASDAQ:DOGZ) jumped 40% to $7.42.
    • Cue Health Inc. (NASDAQ:HLTH) gained 36.8% to $0.2224 after falling 42% on Friday.
    • Voyager Therapeutics, Inc. (NASDAQ:VYGR) surged 34% to $11.38 after the company announced a strategic collaboration and capsid license agreement with Novartis to advance potential gene therapies for Huntington's disease and spinal muscular atrophy.
    • RiskOn International, Inc. (NASDAQ:ROI) shares climbed 33.5% to $0.4450 after gaining around 17% on Friday. RiskOn International recently said it expects to announce its new generative AI platform and unveil a principal technology partner on Jan. 3.
    • Soligenix, Inc. (NASDAQ:SNGX) shares gained 33.4% to $1.01. Soligenix announced publication demonstrating complete protection against filovirus disease in nonhuman primate models of ebola and marburg viruses.
    • SenesTech, Inc. (NASDAQ:SNES) gained 22.2% to $1.56. SenesTech announced the expansion of its distribution agreement with Pesterminators Pvt Ltd to include the deployment of EvolveTM.
    • Brooge Energy Limited (NASDAQ:BROG) jumped 17.1% to $4.31. Brooge Energy recently announced that it reached a settlement with the SEC where it agreed to pay a $5 million penalty and cease any future violations.
    • Lyell Immunopharma, Inc. (NASDAQ:LYEL) gained 16.9% to $2.26.
    • Wheels Up Experience Inc. (NYSE:UP) surged 16.9% to $4.01.
    • BTCS Inc. (NASDAQ:BTCS) shares rose 14.1% to $1.8593 amid strength in Bitcoin.
    • Allogene Therapeutics, Inc. (NASDAQ:ALLO) gained 12% to $3.59.
    • Precigen, Inc. (NASDAQ:PGEN) rose 11.9% to $1.50.
    • Argo Blockchain plc (NASDAQ:ARBK) shares gained 11.8% to $4.18 after falling 8% on Friday.
    • MicroStrategy Incorporated (NASDAQ:MSTR) gained 11.4% to $703.40 after Bitcoin rose above $45,000.
    • Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) rose 10.8% to $19.43.
    • MannKind Corporation (NASDAQ:MNKD) gained 9.9% to $4.0001. MannKind sold a 1% royalty in net sales of Tyvaso DPI (Treprostinil) inhalation powder in exchange for up to $200 million, including the purchase price of $150 million and an additional potential milestone payment of up to $50 million.
    • Moderna, Inc. (NASDAQ:MRNA) climbed 9.8% to $109.18 after Openheimer upgraded the stock from Perform to Outperform.
    • Alpha and Omega Semiconductor Limited (NASDAQ:AOSL) gained 8.8% to $28.36. B. Riley Securities analyst Craig Ellis upgraded Alpha & Omega from Neutral to Buy and raised the price target from $28 to $34.
    • Hut 8 Corp. (NASDAQ:HUT) gained 6.3% to $14.19 amid strength in Bitcoin.
    • CleanSpark, Inc. (NASDAQ:CLSK) gained 6.2% to $11.71 amid strength in Bitcoin.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) shares jumped 6% to $24.88 amid strength in Bitcoin.
    • Riot Platforms, Inc. (NASDAQ:RIOT) surged 5.3% to $16.29 mid strength in Bitcoin.

    Losers

    • RenovoRx, Inc. (NASDAQ:RNXT) shares tumbled 29.9% to $1.6050.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) fell 28.8% to $2.8250 after gaining 92% on Friday.
    • Sentage Holdings Inc. (NASDAQ:SNTG) shares fell 28.8% to $3.56 after jumping over 182% on Friday.
    • LumiraDx Limited (NASDAQ:LMDX) fell 28.7% to $0.0459. LumiraDx agreed to sell its point-of-care technology platform to Roche.
    • Corcept Therapeutics Incorporated (NASDAQ:CORT) fell 26.3% to $23.93 after the company announced the Court for the District of New Jersey issued a decision that Teva Pharmaceuticals does not infringe any asserted claims of Corcept's U.S. Patents 10,195,214 and 10,842,800.
    • Anavex Life Sciences Corp. (NASDAQ:AVXL) shares fell 26.2% to $6.88 after the company provided an update on Rett Syndrome program.
    • Mobix Labs, Inc. (NASDAQ:MOBX) fell 25.6% to $2.9895.
    • FLJ Group Limited (NASDAQ:FLJ) shares fell 21% to $1.58 after surging 48% on Friday.
    • Aditxt, Inc. (NASDAQ:ADTX) shares fell 21% to $5.24 after jumping around 38% on Friday.
    • Vertex Energy, Inc. (NASDAQ:VTNR) declined 20.1% to $2.7069 after the company announced it amended its existing term loan agreement, which provides for an incremental $50 million in borrowings to the company.
    • Vast Renewables Limited (NASDAQ:VSTE) fell 17.2% to $4.14.
    • JOYY Inc. (NASDAQ:YY) fell 16.2% to $33.27 after the company announced it received a written notice from an affiliate of Baidu purporting to terminate the Share Purchase Agreement, dated Nov. 16, 2020.
    • GoodRx Holdings, Inc. (NASDAQ:GDRX) dipped 15.5% to $5.66 after B of A Securities downgraded the stock from Buy to Underperform and lowered its price target from $8 to $4.5.
    • China Green Agriculture, Inc. (NYSE:CGA) shares fell 15.2% to $2.57 after jumping over 59% on Friday.
    • KORE Group Holdings, Inc. (NYSE:KORE) shares fell 13.8% to $0.8451 after jumping over 40% on Friday.
    • Aurora Innovation, Inc. (NASDAQ:AUR) fell 13.8% to $3.7605 after the company filed for an $850 million mixed securities shelf offering.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) declined 13.5% to $8.86.
    • Bitdeer Technologies Group (NASDAQ:BTDR) fell 12.5% to $8.63.
    • Amprius Technologies, Inc. (NYSE:AMPX) fell 11.5% to $4.68.
    • PureTech Health plc (NASDAQ:PRTC) fell 9.6% to $24.79.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) dipped 9.1% to $21.34 after the company reported delivery and production figures for 2023.
    • Fisker Inc. (NYSE:FSR) fell 7.7% to $1.6141.

     

    Now Read This: Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January

    Get the next $ADTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTX
    $AHG
    $ALLO
    $AMPX

    CompanyDatePrice TargetRatingAnalyst
    Allogene Therapeutics Inc.
    $ALLO
    4/16/2026Underweight → Neutral
    Analyst
    Allogene Therapeutics Inc.
    $ALLO
    4/10/2026$6.00Buy
    Jefferies
    Lyell Immunopharma Inc.
    $LYEL
    4/10/2026$44.00Buy
    Needham
    Bitdeer Technologies Group
    $BTDR
    4/9/2026$10.00Overweight → Neutral
    Cantor Fitzgerald
    Rivian Automotive Inc.
    $RIVN
    4/1/2026$14.00Underperform → Neutral
    DA Davidson
    Corcept Therapeutics Incorporated
    $CORT
    3/26/2026Underperform → Peer Perform
    Wolfe Research
    Hut 8 Corp.
    $HUT
    3/23/2026$136.00Buy
    Arete
    Strategy Inc
    $MSTR
    3/10/2026$175.00Buy
    B. Riley Securities
    More analyst ratings

    $ADTX
    $AHG
    $ALLO
    $AMPX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 6, 2023 - FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

    For Immediate Release: June 06, 2023 Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. This test is the first at-home over-the-c

    6/6/23 3:04:14 PM ET
    $HLTH
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADTX
    $AHG
    $ALLO
    $AMPX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $24,061 worth of Class A Shares (72,912 units at $0.33) and sold $3,595 worth of Class A Shares (11,982 units at $0.30), increasing direct ownership by 100% to 121,592 units (SEC Form 4)

    4 - Aditxt, Inc. (0001726711) (Issuer)

    4/23/26 3:43:04 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Castagna Michael bought $259,000 worth of shares (100,000 units at $2.59), increasing direct ownership by 4% to 2,575,911 units (SEC Form 4)

    4 - MANNKIND CORP (0000899460) (Issuer)

    3/10/26 9:30:02 PM ET
    $MNKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHG
    $ALLO
    $AMPX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wheels Up Announces Changes to Board of Directors

    Delta CFO Erik Snell to Join the Board, Replacing Delta COO Dan JankiTimothy Armstrong to Retire from the Board at the 2026 Annual Meeting of Stockholders and Roger Farah Expected to be Nominated for ElectionATLANTA, April 24, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) ("Wheels Up" or the "Company") today announced that Erik Snell, Executive Vice President and Chief Financial Officer of Delta Air Lines, Inc. ("Delta") has been appointed to the Company's Board of Directors (the "Board") as a Delta designee, replacing Dan Janki, Executive Vice President and Chief Operating Officer of Delta. Mr. Snell previously served on the Board from July 2021 to September 2023.

    4/24/26 6:55:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

    Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quarter financial results and provide a corporate update on April 30, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number and a unique access PIN. Each access PIN will accommodate one caller. Additionally, a listen-only webcast will be available by clicking here. A replay of the call will be available on the Investors / Events tab of Corcept.com. About Corcept Therapeut

    4/23/26 4:05:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

    LONDON, April 23, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 28, 2026 at 8:30 a.m. Eastern Time to report its first quarter 2026 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company's website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and reg

    4/23/26 4:01:00 PM ET
    $KNSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHG
    $ALLO
    $AMPX
    SEC Filings

    View All

    SEC Form DEFA14A filed by Wheels Up Experience Inc.

    DEFA14A - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 7:07:27 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    SEC Form DEF 14A filed by Wheels Up Experience Inc.

    DEF 14A - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 7:05:29 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Wheels Up Experience Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 6:56:02 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    $ADTX
    $AHG
    $ALLO
    $AMPX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Finance Yoshiyama Annie sold $22,144 worth of shares (9,586 units at $2.31), decreasing direct ownership by 7% to 124,517 units (SEC Form 4) to satisfy withholding tax

    4 - Allogene Therapeutics, Inc. (0001737287) (Issuer)

    4/23/26 4:16:11 PM ET
    $ALLO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Hrt Financial Lp bought $24,061 worth of Class A Shares (72,912 units at $0.33) and sold $3,595 worth of Class A Shares (11,982 units at $0.30), increasing direct ownership by 100% to 121,592 units (SEC Form 4)

    4 - Aditxt, Inc. (0001726711) (Issuer)

    4/23/26 3:43:04 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Hrt Financial Lp claimed ownership of 133,574 units of Class A Shares (SEC Form 3)

    3 - Aditxt, Inc. (0001726711) (Issuer)

    4/23/26 3:37:12 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHG
    $ALLO
    $AMPX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Allogene upgraded by Analyst

    Analyst upgraded Allogene from Underweight to Neutral

    4/16/26 7:57:56 AM ET
    $ALLO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Jefferies resumed coverage on Allogene with a new price target

    Jefferies resumed coverage of Allogene with a rating of Buy and set a new price target of $6.00

    4/10/26 12:25:15 PM ET
    $ALLO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Needham initiated coverage on Lyell Immunopharma with a new price target

    Needham initiated coverage of Lyell Immunopharma with a rating of Buy and set a new price target of $44.00

    4/10/26 8:32:14 AM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHG
    $ALLO
    $AMPX
    Leadership Updates

    Live Leadership Updates

    View All

    Wheels Up Announces Changes to Board of Directors

    Delta CFO Erik Snell to Join the Board, Replacing Delta COO Dan JankiTimothy Armstrong to Retire from the Board at the 2026 Annual Meeting of Stockholders and Roger Farah Expected to be Nominated for ElectionATLANTA, April 24, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) ("Wheels Up" or the "Company") today announced that Erik Snell, Executive Vice President and Chief Financial Officer of Delta Air Lines, Inc. ("Delta") has been appointed to the Company's Board of Directors (the "Board") as a Delta designee, replacing Dan Janki, Executive Vice President and Chief Operating Officer of Delta. Mr. Snell previously served on the Board from July 2021 to September 2023.

    4/24/26 6:55:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Samsara to Accelerate the Future of Physical AI at HumanX 2026

    Aurora, Semafor, and Serve Robotics to join Samsara for a masterclass on the mixed-autonomy revolution Samsara (NYSE:IOT), the pioneer of the Connected Operations Platform, today announced it will participate in HumanX 2026, the world's premier AI conference. On Wednesday, April 8, 2026, at the Moscone Center, Samsara is defining the next frontier of physical AI—the integration of artificial intelligence into the physical systems that power the world's infrastructure. Serving as a crucial orchestration layer between autonomous vehicles (AVs), robotics, and human-led operations, Samsara is showcasing how it provides a unifying view of the complex ecosystem where human operators, autonomous

    3/31/26 9:00:00 AM ET
    $AUR
    $IOT
    $SERV
    EDP Services
    Technology
    Industrial Specialties
    Consumer Discretionary

    Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer

    Busch brings public company leadership and capital markets experience to support Ignite's next phase of growth Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its subsidiary, Ignite Proteomics, LLC ("Ignite" or "Ignite Proteomics"). Ignite Proteomics was recently acquired by Aditxt and operates a commercial-stage precision oncology platform designed to guide cancer therapy selection through functional protein profiling. The platform measures active proteins inside tumors to help oncologists determine which targeted therapies are most

    3/19/26 8:15:00 AM ET
    $ADTX
    $GMRE
    $XRN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    $ADTX
    $AHG
    $ALLO
    $AMPX
    Financials

    Live finance-specific insights

    View All

    Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

    Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quarter financial results and provide a corporate update on April 30, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number and a unique access PIN. Each access PIN will accommodate one caller. Additionally, a listen-only webcast will be available by clicking here. A replay of the call will be available on the Investors / Events tab of Corcept.com. About Corcept Therapeut

    4/23/26 4:05:00 PM ET
    $CORT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

    LONDON, April 23, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 28, 2026 at 8:30 a.m. Eastern Time to report its first quarter 2026 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company's website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and reg

    4/23/26 4:01:00 PM ET
    $KNSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amprius Technologies Announces Date for First Quarter 2026 Results and Business Updates

    Amprius Technologies, Inc. ("Amprius"), (NYSE:AMPX), a leader in silicon anode lithium-ion batteries, will hold a conference call and webcast on Thursday, May 7, 2026 at 8:30 a.m. Eastern time (5:30 a.m. Pacific time) to discuss its financial results for the first quarter ended March 31, 2026. Financial results will be issued in a press release prior to the call. Amprius management will host the presentation, followed by a question-and-answer period. Date: Thursday, May 7, 2026 Time: 8:30 a.m. ET (5:30 a.m. PT) Toll-Free Number: 866-424-3442 International Number: 201-689-8548 Webcast: Register and Join Please call the conference telephone number 5-10 minutes prior to the start time. A

    4/21/26 8:30:00 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    $ADTX
    $AHG
    $ALLO
    $AMPX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by JOYY Inc.

    SC 13G/A - JOYY Inc. (0001530238) (Subject)

    11/14/24 7:58:46 PM ET
    $YY
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by ToughBuilt Industries Inc.

    SC 13G/A - Toughbuilt Industries, Inc (0001668370) (Subject)

    11/14/24 7:29:15 PM ET
    $TBLT
    Industrial Machinery/Components
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials